DZIP3 is associated with the cytoskeletal dynamics in glioblastoma and mitochondrial machinery regulation
5 affiliations
- 1Immunopathology-Immunotherapy-Immunomonitoring Laboratory, Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS) , ,
- 2AI and Data Science Service, Mohammed VI Center for Research and Innovation (CM6RI) , ,
- 3Department of Neurosurgery, Cheikh Khalifa International University Hospital , ,
- 4Department of Biological Sciences, Faculty of Medicine, Mohammed VI University of Health Sciences , ,
- 5Department of Obstetrics and Gynecology, Mohammed VI International University Hospital , ,
Abstract
Glioblastoma (GBM) is a major public health issue with increased prevalence and incidence worldwide. The therapeutic strategy is based on surgical resection, followed by chemotherapy and radiotherapy. However, therapeutic failure is increasingly recognized as driven by the intricate characteristics of the tumor microenvironment (TME). Stress granules (SGs) are structures that emerge in cells in response to stress. In GBM, these elements are implicated in tumor development and progression. Heterogeneous elements coalesce to form SGs, with RNA-binding proteins (RBPs) among them. DZIP3, DAZ-interacting zinc finger 3, is an understudied RBP in cancer, particularly with respect to its impact on TME remodeling. In the current study, we evaluate the prognostic value of DZIP3 using The Cancer Genome Atlas and the Chinese Glioma Genome Atlas as the validation cohort. Furthermore, we identified enriched pathways associated with upregulated genes linked to high DZIP3 expression. The correlation between these gene sets and DZIP3 was validated using a robustness assessment. We also identified the core hub miRNAs that target DZIP3 by using validated miRNA databases. Our results revealed that initially, high DZIP3 expression was associated with better survival in the TCGA cohort, but after adjustment for age, gender, transcription subtypes, IDH mutation status, MGMT promoter methylation status, and Karnofsky performance score, the prognostic utility of DZIP3 did not persist. Similar results were observed in the CGGA cohort. Of the 30 enriched pathways obtained, only 7 retained independent association: the cytoskeletal dynamics/intracellular transport gene set was the strongest correlate of DZIP3, followed by 4 mitochondrial modules (branched-chain amino acid metabolism, NAD biosynthesis, translation factors, and pyruvate metabolism), RNA granule/neurodegeneration gene set, and the nucleocytoplasmic transport gene set. The immune checkpoints, P-bodies, and malignant cell state gene sets were not independent of this signal. The cytoskeletal signal was replicated in the CGGA cohort and at single-cell resolution, with 9 core hub miRNAs targeting DZIP3, suspected to be a regulatory mechanism. Altogether, this study identifies the cytoskeletal module, 4 mitochondrial programs, RNA granule/neurodegeneration, and nucleocytoplasmic transport gene sets as the strongest correlates of DZIP3 expression in GBM, demonstrating that clinical prognostic value is distinct from transcriptional reproducibility.
Related
- Lipid droplet-associated proteins integrate lipid metabolism, cell cycle, and cytoskeletal remodeling in colon cancer
- Heterogeneous and conserved radiation responses reveal FOXM1-dependent regulation of microcephaly genes in glioblastoma
- Dissecting the reciprocal association between cytoskeletal mechanics and senescence-associated phenotypes in human dermal fibroblasts
- FTO-mediated m6A regulation modulates hepatic stellate cell activation through the IGF2BP1–TRIB3 axis and mitochondrial homeostasis
- G-protein coupled estrogen receptor 1 (GPER1) expression improves survival of glioblastoma patients depending on sex and age: biological mechanisms and epigenetic regulation
BibTeX
@article{bichri2026dzip3,
title = {{DZIP3 is associated with the cytoskeletal dynamics in glioblastoma and mitochondrial machinery regulation}},
author = {Khadija Bichri and Imad El Badisy and Mounir Rghioui and Meryem Chihab-Eddine and Mohammed Sqalli Houssaini and Bouchra Ghazi},
journal = {Frontiers in bioinformatics},
year = {2026},
month = oct,
doi = {10.3389/fbinf.2026.1878616},
url = {https://europepmc.org/article/PMC/PMC13717357},
note = {CC BY},
}
RIS
TY - JOUR
TI - DZIP3 is associated with the cytoskeletal dynamics in glioblastoma and mitochondrial machinery regulation
AU - Khadija Bichri
AU - Imad El Badisy
AU - Mounir Rghioui
AU - Meryem Chihab-Eddine
AU - Mohammed Sqalli Houssaini
AU - Bouchra Ghazi
PY - 2026
DA - 2026/10/15
JO - Frontiers in bioinformatics
DO - 10.3389/fbinf.2026.1878616
UR - https://europepmc.org/article/PMC/PMC13717357
AB - Glioblastoma (GBM) is a major public health issue with increased prevalence and incidence worldwide. The therapeutic strategy is based on surgical resection, followed by chemotherapy and radiotherapy. However, therapeutic failure is increasingly recognized as driven by the intricate characteristics of the tumor microenvironment (TME). Stress granules (SGs) are structures that emerge in cells in response to stress. In GBM, these elements are implicated in tumor development and progression. Heterogeneous elements coalesce to form SGs, with RNA-binding proteins (RBPs) among them. DZIP3, DAZ-interacting zinc finger 3, is an understudied RBP in cancer, particularly with respect to its impact on TME remodeling. In the current study, we evaluate the prognostic value of DZIP3 using The Cancer Genome Atlas and the Chinese Glioma Genome Atlas as the validation cohort. Furthermore, we identified enriched pathways associated with upregulated genes linked to high DZIP3 expression. The correlation between these gene sets and DZIP3 was validated using a robustness assessment. We also identified the core hub miRNAs that target DZIP3 by using validated miRNA databases. Our results revealed that initially, high DZIP3 expression was associated with better survival in the TCGA cohort, but after adjustment for age, gender, transcription subtypes, IDH mutation status, MGMT promoter methylation status, and Karnofsky performance score, the prognostic utility of DZIP3 did not persist. Similar results were observed in the CGGA cohort. Of the 30 enriched pathways obtained, only 7 retained independent association: the cytoskeletal dynamics/intracellular transport gene set was the strongest correlate of DZIP3, followed by 4 mitochondrial modules (branched-chain amino acid metabolism, NAD biosynthesis, translation factors, and pyruvate metabolism), RNA granule/neurodegeneration gene set, and the nucleocytoplasmic transport gene set. The immune checkpoints, P-bodies, and malignant cell state gene sets were not independent of this signal. The cytoskeletal signal was replicated in the CGGA cohort and at single-cell resolution, with 9 core hub miRNAs targeting DZIP3, suspected to be a regulatory mechanism. Altogether, this study identifies the cytoskeletal module, 4 mitochondrial programs, RNA granule/neurodegeneration, and nucleocytoplasmic transport gene sets as the strongest correlates of DZIP3 expression in GBM, demonstrating that clinical prognostic value is distinct from transcriptional reproducibility.
SN - 2673-7647
ER -